
Phoebus Medical Technology, an artificial intelligence-based chronic disease management company, has raised tens of millions of RMB in series A round of financing from healthcare and life sciences-focused Cenova Capital, according to Chinese media reports.

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!